Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note published on Sunday morning. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of NYSE ENZ opened at $0.45 on Friday. The stock’s 50-day moving average is $0.54 and its 200 day moving average is $0.85. Enzo Biochem has a 1-year low of $0.41 and a 1-year high of $1.30.

Enzo Biochem (NYSE:ENZ) last posted its quarterly earnings results on Monday, March 17th. The medical research company reported ($0.02) EPS for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%. The business had revenue of $7.33 million for the quarter.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Virtu Financial LLC purchased a new stake in Enzo Biochem during the 4th quarter valued at about $35,000. Lepercq Multi Asset Fund purchased a new stake in shares of Enzo Biochem during the fourth quarter valued at approximately $88,000. BBR Partners LLC bought a new position in shares of Enzo Biochem in the third quarter worth approximately $112,000. Wittenberg Investment Management Inc. increased its stake in shares of Enzo Biochem by 60.1% in the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after buying an additional 70,400 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Enzo Biochem by 3.3% in the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after buying an additional 11,742 shares during the period. Hedge funds and other institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.